BiomeBank is a clinical stage biotechnology company developing microbial therapies
Business Model:
Revenue: $0
Employees: 11-50
Address: -
City: Adelaide
State: south australia
Zip: 5000
Country: AU
BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat Clostridoides difficile, a potentially life threatening infection, and are positioning the drug product for multiple indications. Furthermore, we are actively developing second generation therapies in multiple diseases, including Ulcerative Colitis and Crohn&s;s Disease.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2022 | Equity | $7.2M |
Ellerston Capital South Australian Venture Capital Fund The Hospital Research Foundation |
12/2022 | Venture Round | 2 | $7.3M |
Ellerston Capital South Australian Venture Capital Fund Ellerston Capital South Australian Venture Capital Fund |
12/2022 | Venture Round | 2 | $7.3M |
Ellerston Capital South Australian Venture Capital Fund Ellerston Capital South Australian Venture Capital Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|